Randa Atwan

Mrs. Randa Atwan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2025 in BMJ Open
Verified
Journal Article
Open access
LGLobna Gharaibeh
Lobna Gharaibeh
MAMariam Alameri
Mariam Alameri
MAMai I Al-Hawamdeh
Mai I Al-Hawamdeh
EDEnas Daoud
Enas Daoud
RARanda Atwan
Randa Atwan
ZZZainab Zakareia
Zainab Zakareia
Objectives: The widespread use of proton pump inhibitors (PPIs) raised concerns on the safety of long-term use of these drugs. Community pharmacists have great responsibility of educating patients on these drugs which requires having adequate knowledge. The aim of this study was to assess the practices and knowledge of community pharmacists regarding PPIs. Design: This was a cross-sectional study conducted by filling in a questionnaire. The questionnaire was developed after a comprehensive literature review and assessed knowledge and practices. Settings: Community pharmacists with at least 1 year of experience working in a community pharmacy were enrolled in the study. Participants: Community pharmacists with at least 1 year of experience working in a community pharmacy were enrolled in the study. Primary outcome measures: The knowledge, attitudes, and practices of community pharmacists towards PPIs dispensing. Results: A total of 459 community pharmacists were approached for participation in the study, 451 (98.3%) community pharmacists agreed to be enrolled. The most dispensed PPIs in Jordan were lansoprazole and the most commonly treated medical condition with PPIs was gastric ulcer. PPIs were dispensed by the pharmacists very frequently and one-fourth of the participants did not review instructions with patients to ensure their proper use of PPIs. Participants had an average knowledge of 6.1±1.7 (the highest knowledge score is 12). More than one-third of participants (180, 39.9%) had inadequate knowledge (a score of less than 6). Being a PharmD graduate was the only significant factor that predicted adequate knowledge in the logistic regression model, with an adjusted OR of 5.671, p=0.002. Conclusion: To provide adequate pharmaceutical care services, community pharmacists must possess appropriate knowledge on different aspects of PPIs concerning administration, efficacy and long-term and short-term side effects.

8 October 2024 in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
MAMariam Alameri
Mariam Alameri
LGLobna Gharaibeh
Lobna Gharaibeh
MAMai I. Al-Hawamdeh
Mai I. Al-Hawamdeh
RARanda Atwan
Randa Atwan
EDEnas Daoud
Enas Daoud
Background: Proton pump inhibitors (PPIs) are frequently used for the treatment and prophylaxis of upper gastrointestinal tract disorders. PPIs are now frequently the first-choice treatment for people with diseases associated with acidity. Objectives: The aim of this study is to assess the awareness, knowledge, and behaviour of the Jordanian public regarding the misuse and overuse of proton pump inhibitors. Methodology: The survey was made with Google Forms and made available online through various social media channels. Using a practical sample technique and the snowball dissemination of the questionnaire, participants were recruited. Adulthood and residence in the Hashemite Kingdom of Jordan were requirements for inclusion. Results: A total of 418 participants responded and filled out the questionnaire, with an average age of 37.5 ± 14.2 years. almost one third experienced a GI disease, n = 115 (27.5%), but around half of the participants, 204 (48.8%), used at least one type of PPI. 88 (43.1%) of the participants who used the PPIs experienced vitamin B12 deficiency as the most frequent side effect. The knowledge score was calculated for participants; the overall knowledge score was very low (2.8/8); the lowest score was on the correct duration for PPI use (0.13/1). In the multivariate analysis, predictors of a higher score of knowledge were working in a medical field and a monthly income lower than 500 JD. Conclusion: Findings from this study demonstrated that the overall knowledge score for Jordanians was low, which indicates that the Jordanian public is unaware of the PPIs correct use and possible side effects. Hence, with the dramatic increase in PPIs use, educational initiatives and programs are required to enhance public knowledge, particularly among those with non-medical educational backgrounds and monthly income above 500 JD.

2 November 2026 in Polymers
Verified
Journal Article
Open access
PDF file
SMSina Mahmoud Matalqah
Sina Mahmoud Matalqah
ZLZainab Lafi
Zainab Lafi
RARanda Atwan
Randa Atwan
SASara Yousef Asha
Sara Yousef Asha
AMAsem N. Mhaidat
Asem N. Mhaidat
Direct nose-to-brain drug delivery is emerging as a promising approach in neuro-oncology because it offers a non-invasive, needle-free route for delivering therapeutics to the brain while partially bypassing the blood–brain barrier (BBB). This approach takes advantage of the natural connections between the nasal cavity and the central nervous system, allowing drugs administered through the nose to reach brain tissues through the olfactory and trigeminal pathways. Despite its potential, successful clinical translation remains challenging because the nasal cavity presents several physiological barriers. Mucus can trap drug molecules, mucociliary clearance can rapidly remove them, and nasal enzymes can degrade them before they reach their target. Advanced nanocarrier systems are therefore being developed to overcome these barriers and improve drug transport through intracellular, paracellular, and transcellular pathways. In this context, specific structural modifications can enhance drug retention, mucus penetration, cellular uptake, and targeting efficiency. Important strategies include the use of mucoadhesive materials such as chitosan to increase residence time in the nasal cavity; hydrophilic coatings such as polyethylene glycol (PEG) to improve movement through mucus; targeting ligands to promote selective cellular uptake; and stimuli-responsive systems that respond to local conditions such as pH, redox state, or glutathione (GSH) levels. These advances are particularly relevant to the treatment of glioblastoma multiforme (GBM), one of the most aggressive and difficult-to-treat brain tumors. GBM is characterized by extensive infiltration into surrounding healthy brain tissue, making it difficult to achieve effective drug concentrations throughout both the main tumor mass and its invasive margins. Intranasally delivered chitosan-based nano-formulations may help address this problem through a series of transport steps. After administration, the nanoparticles can interact with and remain within the nasal mucosa, move across the olfactory epithelium, and pass through the cribriform plate toward the olfactory bulb. From there, they may distribute into deeper regions of the brain and potentially increase drug accumulation within both the GBM core and infiltrative tumor regions. This review presents a structured overview of engineered chitosan nano-formulations for targeted drug delivery in neuro-oncology. It focuses on their physicochemical properties, mechanisms of nose-to-brain transport, drug-loading strategies, tumor-targeting approaches, therapeutic applications, and the major challenges that must be addressed before clinical translation. Overall, these systems offer a promising strategy for improving the precision and effectiveness of drug delivery to brain tumors and may contribute to the development of more targeted treatments for GBM and other neurological malignancies.